论文部分内容阅读
目的对达那唑栓在复发性子宫内膜异位症患者临床治疗中的应用效果观察。方法 88例复发性子宫内膜异位症患者,随机分为对照组和观察组,各44例。对照组患者口服达那唑栓治胶囊治疗,观察组患者阴道或肛门应用达那唑栓治疗,对比分析两组患者的临床治疗效果和不良反应。结果观察组患者的临床体征治疗有效性显著高于对照组,对比差异有统计学意义(P<0.05);观察组患者的临床治疗总有效率为95.5%高于对照组的84.1%,差异具有统计学意义(P<0.05);两组患者的临床治疗不良反应发生率对比差异无统计学意义(P>0.05)。结论在复发性子宫内膜异位症患者临床治疗中应用达那唑栓,实施经阴道或肛门治疗方式,临床治疗效果显著优于口服治疗效果,值得推广应用。
Objective To observe the effect of danazol suppository in the clinical treatment of patients with recurrent endometriosis. Methods 88 patients with recurrent endometriosis were randomly divided into control group and observation group, 44 cases in each group. The patients in the control group were treated with danazol Zhibi capsule. The patients in the observation group were given danazol suppositories for vaginal or anterior analgesia. The clinical effects and adverse reactions of the two groups were compared. Results The clinical efficacy of the observation group was significantly higher than that of the control group (P <0.05). The total effective rate of clinical observation in the observation group was 95.5% higher than that of the control group (84.1%), the differences were statistically significant (P <0.05). There was no significant difference in the incidence of clinical adverse reactions between the two groups (P> 0.05). Conclusion In the clinical treatment of patients with recurrent endometriosis danazol suppository, the implementation of transvaginal or anal treatment, the clinical treatment was significantly better than the oral treatment effect, it is worth promoting the application.